Abiopharma

Novo Nordisks Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America

Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations

AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference

Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference

Lineage Cell Therapeutics Issues Letter to Stockholders

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism

Esperion to Participate in Upcoming 44th Annual J.P. Morgan Healthcare Conference

Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials

Stryker to announce financial results for its fourth quarter and full year 2025